Citation Impact
Citing Papers
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
2012 Standout
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
2023 Standout
Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
2022 Standout
Therapeutic potential of flavonoids in cancer: ROS-mediated mechanisms
2022
Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge
2017 StandoutNobel
Neural progenitor cell-derived nanovesicles promote hair follicle growth via miR-100
2021
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
2016 Standout
Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction
2011
Liraglutide: the therapeutic promise from animal models
2010
The Cardiovascular Biology of Glucagon-like Peptide-1
2016
Glucagon-Like Peptide-1 and Its Class B G Protein–Coupled Receptors: A Long March to Therapeutic Successes
2016
Monocyte chemoattractant protein-1 enhances expression of intercellular adhesion molecule-1 following ischemia-reperfusion of the liver in rats
1998
Novel therapeutic targets for the treatment of heart failure
2011
Microbial tryptophan catabolites in health and disease
2018 Standout
ROS in cancer therapy: the bright side of the moon
2020 Standout
Lipid nanoparticles for mRNA delivery
2021 Standout
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
The pathogenesis of cardiac fibrosis
2013 Standout
Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo
2015
Trends in GPCR drug discovery: new agents, targets and indications
2017 Standout
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
2015 Standout
Myocardial ischemia-reperfusion injury: a neglected therapeutic target
2013 Standout
The changing landscape of atherosclerosis
2021 StandoutNature
Cardiovascular effects of Glucagon-like peptide 1 (GLP-1) receptor agonists
2014
Cell Biology of Ischemia/Reperfusion Injury
2012 Standout
Targeting the Chemokines in Cardiac Repair
2014
The potential effects of anti-diabetic medications on myocardial ischemia–reperfusion injury
2011
Chemokines in the ischemic myocardium: from inflammation to fibrosis
2004
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Enhanced expression of B7-1, B7-2, and intercellular adhesion molecule 1 in sinusoidal endothelial cells by warm ischemia/reperfusion injury in rat liver
2001 StandoutNobel
Cardiovascular effects of gliptins
2013
Chemokine Expression in Myocardial Ischemia: MIP-2 Dependent MCP-1 Expression Protects Cardiomyocytes from Cell Death
2002
Type 2 diabetes mellitus and the cardiometabolic syndrome: impact of incretin-based therapies
2010
Non-viral vectors for gene-based therapy
2014 Standout
GLP-1 agonist-based therapies: An emerging new class of antidiabetic drug with potential cardioprotective effects
2009
Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study
2019 Standout
Incretins as a novel therapeutic strategy in patients with diabetes and heart failure
2012
The design and rationale of the Saxagliptin Assessment of Vascular Outcomes Recorded in patients with diabetes mellitus–Thrombolysis in Myocardial Infarction (SAVOR-TIMI) 53 Study
2011
Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
2013 Standout
GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus
2012
Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury
2000 Standout
Mechanisms of Hepatic Fibrogenesis
2008 Standout
A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care—an international randomised controlled trial
2012 Standout
The potential for renoprotection with incretin-based drugs
2014
Molecular and cellular basis of the anticancer activity of the prenylated flavonoid icaritin in hepatocellular carcinoma
2020
Type 1 diabetes
2013 Standout
Upregulation of cell adhesion molecules and the presence of low grade inflammation in human chronic heart failure
1997
Human Mesenchymal Stem Cells as a Carrier for a Cell-Mediated Drug Delivery
2022 StandoutNobel
mRNA transcript therapy
2014 StandoutNobel
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2012 Standout
Peptide therapeutics: current status and future directions
2014 Standout
The Discovery and Development of Liraglutide and Semaglutide
2019
A Systematic Assessment of Cardiovascular Outcomes in the Saxagliptin Drug Development Program for Type 2 Diabetes
2010
Dipeptidyl peptidase IV inhibitors as novel regulators of vascular disease
2017
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
2015 Standout
Type 2 diabetes mellitus
2015 Standout
Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction
2013
Cardiovascular Effects of Glucagonlike peptide–1 Agonists
2011
Expression and Regulation of Cell Adhesion Molecules by Hepatic Stellate Cells (HSC) of Rat Liver
1999
Diabetic cardiomyopathy: Mechanisms and new treatment strategies targeting antioxidant signaling pathways
2014
Inhibition of IκB phosphorylation in cardiomyocytes attenuates myocardial ischemia/reperfusion injury
2004
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
2013 Standout
G-Protein-Coupled Receptors in Intestinal Chemosensation
2012
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis
2010
Novel fusion of GLP-1 with a domain antibody to serum albumin prolongs protection against myocardial ischemia/reperfusion injury in the rat
2013
Molecular Regulation of Vascular Smooth Muscle Cell Differentiation in Development and Disease
2004 Standout
Cardiac Intercellular Communication: Are Myocytes and Fibroblasts Fair-Weather Friends?
2012
Effects of intravenous exenatide in type 2 diabetic patients with congestive heart failure: a double-blind, randomised controlled clinical trial of efficacy and safety
2012
Enhanced expression and production of monocyte chemoattractant protein-1 in myocarditis
2001
Expression and Regulation of Adhesion Molecules in Cardiac Cells by Cytokines
1998
Lipid-Based Nanovesicular Drug Delivery Systems
2021
Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy
2008 Standout
Cardiovascular Biology of the Incretin System
2012
Antisense to LOX-1 Inhibits Oxidized LDL–Mediated Upregulation of Monocyte Chemoattractant Protein-1 and Monocyte Adhesion to Human Coronary Artery Endothelial Cells
2000 Standout
Endoplasmic Reticulum Stress As a Therapeutic Target in Cardiovascular Disease
2010
A new class of obesity genes encodes leukocyte adhesion receptors
1997
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
Hydrolyzed Infant Formula and Early β-Cell Autoimmunity
2014
Diabetic Cardiomyopathy
2018 Standout
Ionizable lipid nanoparticles deliver mRNA to pancreatic β cells via macrophage-mediated gene transfer
2023 StandoutNobel
NRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis
2016
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Type 2 diabetes mellitus and the cardiometabolic syndrome: impact of incretin-based therapies
2010
Glp-1 analog, liraglutide, ameliorates hepatic steatosis and cardiac hypertrophy in C57BL/6J mice fed a Western diet
2011
Diabetic Kidney Disease
2017 Standout
Once-Weekly Semaglutide in Adults with Overweight or Obesity
2021 Standout
The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis
2018 Standout
Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes
2015
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
The Biological Basis for Cardiac Repair After Myocardial Infarction
2016 Standout
Monocyte Chemoattractant Protein-1 is Upregulated in Rats With Volume-Overload Congestive Heart Failure
2000
CC Chemokine Receptor-2 Deficiency Attenuates Oxidative Stress and Infarct Size Caused by Myocardial Ischemia-Reperfusion in Mice
2006
Mechanisms of Diabetic Complications
2013 Standout
Suppressive Role of Endogenous Endothelial Monocyte Chemoattractant Protein–1 on Monocyte Transendothelial Migration In Vitro
1995
Baseline characteristics of the patient population in the Saxagliptin Assessment of Vascular Outcomes Recorded in patients with diabetes mellitus (SAVOR)‐TIMI 53 trial
2013
Reactive Oxygen Species in Metabolic and Inflammatory Signaling
2018 Standout
Cardiovascular Actions of Incretin-Based Therapies
2014
GPR119 Is Essential for Oleoylethanolamide-Induced Glucagon-Like Peptide-1 Secretion From the Intestinal Enteroendocrine L-Cell
2009
Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010
2012 Standout
GLP-1 receptor agonists today
2011
Expression of Intracellular Adhesion Molecule 1 by Activated Hepatic Stellate Cells
1996
Glucagon-Like Peptide-1 Receptor Agonists for Diabetes Mellitus
2014
Induction of Monocyte Chemoattractant Protein-1 Synthesis in Human Monocytes During Transendothelial Migration In Vitro
1995
Important Flavonoids and Their Role as a Therapeutic Agent
2020 Standout
Works of Kiwon Ban being referenced
Purification of Cardiomyocytes From Differentiating Pluripotent Stem Cells Using Molecular Beacons That Target Cardiomyocyte-Specific mRNA
2013
Cardioprotective and Vasodilatory Actions of Glucagon-Like Peptide 1 Receptor Are Mediated Through Both Glucagon-Like Peptide 1 Receptor–Dependent and –Independent Pathways
2008
Genetic Deletion or Pharmacological Inhibition of Dipeptidyl Peptidase-4 Improves Cardiovascular Outcomes After Myocardial Infarction in Mice
2010
Expression of intercellular adhesion molecule-1 on rat cardiac myocytes by monocyte chemoattractant protein-1
1994
Cardiovascular consequences of drugs used for the treatment of diabetes: potential promise of incretin—based therapies
2009
Regulation of the Intracellular ROS Level Is Critical for the Antiproliferative Effect of Quercetin in the Hepatocellular Carcinoma Cell Line HepG2
2019
GLP-1R Agonist Liraglutide Activates Cytoprotective Pathways and Improves Outcomes After Experimental Myocardial Infarction in Mice
2009
Glucagon-Like Peptide (GLP)-1(9-36)Amide-Mediated Cytoprotection Is Blocked by Exendin(9-39) Yet Does Not Require the Known GLP-1 Receptor
2010
Nanovesicles derived from iron oxide nanoparticles–incorporated mesenchymal stem cells for cardiac repair
2020